Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
Molecular Carcinogenesis|March 1, 1996
Activation and inhibition of the AP-1 complex in human breast cancer cellsT K Chen, L M Smith, D K Gebhardt, et al.Molecular and Cellular Biology|June 1, 1988
L-myc cooperates with ras to transform primary rat embryo fibroblastsM J Birrer, S Segal, J S DeGreve, et al.The Journal of Biological Chemistry|May 26, 1995
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-JunM Cippitelli, A Sica, V Viggiano, et al.British Journal of Cancer|November 20, 2008
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cellsJ Kikuchi, I Kinoshita, Y Shimizu, et al.British Journal of Cancer|February 20, 2008
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutantY Shimizu, I Kinoshita, J Kikuchi, et al.Molecular Carcinogenesis|September 3, 1998
RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cellsW Yu, M Simmons-Menchaca, H You, et al.Circulation Research|September 4, 1999
c-Jun triggers apoptosis in human vascular endothelial cellsN Wang, L Verna, S Hardy, et al.Leukemia|December 9, 1998
The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicityP Dent, W D Jarvis, M J Birrer, et al.Cancer Research|October 28, 1999
Abnormal Fhit expression in malignant and premalignant lesions of the cervixM J Birrer, D Hendricks, J Farley, et al.Molecular and Cellular Biology|December 1, 1991
The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cellsR Alani, P Brown, B Binétruy, et al.Pageof 9